Eyedeal Successfully Holds Clinical Trial Summary Meeting for the World’s New-Generation Cross-Linked polyisobutylene Intraocular Lens (IOL)
On December 15, 2023, Eyedeal successfully held the Clinical Trial Summary…
Clinical Outcomes of Eyedeal’s PA60AS1 Monofocal Intraocular Lens
From 2019 to 2021, Xi’an Eyedeal Medical Technology Co., Ltd. conducted a…
CSBM2023 | Dr. Leonard Pinchuk, a member of the U.S. National Academy of Engineering and Chairman of the Scientific Advisory Board of Xi'an Eyedeal Medical, gave a plenary Lecture on the topic of biomaterials at the Chinese Biomaterials Congress
On October 12 to 15, the 2023 Chinese Biomaterials Congress (CSBM2023) was held…
Eyedeal’s “Cross-linked Polyisobutylene Intraocular Lens” Named One of the Top 100 Most Innovative Medical Device Products (Solutions) of 2023
Recently, at the 2023 Medical Device Product Innovation and International…
Eyedeal Completes RMB 100 Million Series B Financing to Accelerate Product Commercialization
Recently, Xi’an Eyedeal Medical Technology Co., Ltd. announced the successful…
Eyedeal Completes Enrollment for First Toric Intraocular Lens Clinical Trial in China
On April 18, Xi’an Eyedeal Medical Technology Co., Ltd. announced the…
Eyedeal Selected for KPMG China’s Second Annual “Biotech Innovation 50” List
On April 7, the KPMG China 2nd Biotech Innovation 50 Awards Ceremony was held…
Eyedeal’s Premium Foldable Intraocular Lens Approved for Market Launch
Recently, the National Medical Products Administration (NMPA) announced the…
Professor Gerd U. Auffarth, world-renowned cataract expert and scientific advisor of Eyedeal Medical, received AAO Lifetime Achievement Award
The American Academy of Ophthalmology (AAO) recently presented Professor Gerd…
ExThera Medical’s CEO Bob Ward Receives Prestigious BioMedSA Award for Innovation in Healthcare and Bioscience Including a Groundbreaking Device to Treat COVID-19
Editor's note: Robert Ward, member of the Scientific Advisory Committee of…